The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 ...

Novo launched the NovoPen - the first insulin pen device in 1985. Lars Rebien Sorensen becomes CEO after serving as the head of Novo’s healthcare business. The company’s enzymes business was ...

Novo launched the NovoPen - the first insulin pen device in 1985. Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business. The company's enzymes business was spun off ...

Novo Nordisk ... people needing insulin still had multiple options available in the country. Diabetologist V Mohan said that people who were using the more expensive pen device could shift ...

The first 10 drugs targeted for negotiations were announced the following year — Novo’s rapid-acting insulin medication NovoLog among them — and new prices, agreed upon in 2024, are set to take effect ...

South Africa's competition watchdog probes Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market South Africa’s competition watchdog is investigating ...

Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa’s Competition ...